Home › NDC Lookup › RxCUI directory › RxCUI 2641918

{14 (perampanel 2 MG Oral Tablet) } Pack — RxCUI 2641918

Name: {14 (perampanel 2 MG Oral Tablet) } Pack (RxCUI 2641918)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Generic pack

RxCUI 2641918 Generic pack · GPCK ● Current RxNorm concept 7 FDA products 15 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2641918

Official name{14 (perampanel 2 MG Oral Tablet) } Pack

Concept typeGeneric pack (GPCK)

RxNorm statusCurrent RxNorm concept

Also known asperampanel 2 MG 2-Week Sample Kit

FDA products mapped7

Package NDCs mapped15

Reported Medicaid activity (SDUD)63,501 prescriptions · 45 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Perampanel: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Perampanel is a seizure medicine used to treat two types of epilepsy: partial-onset seizures (seizures that start in one part of the brain) and primary generalized tonic-clonic sei...
What is perampanel actually for — why did my doctor prescribe it?
Taking perampanel at bedtime is intentional — it causes dizziness and drowsiness in many people, and sleeping through the worst of that makes it much easier to tolerate. It also he...
Why do I have to take it at bedtime? Can I take it at a different time?

📖 Read our full Perampanel guide →

🕸️ Concept Web — How {14 (perampanel 2 MG Oral Tablet) } Pack Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept {14 (perampanel 2 MG Oral Tablet) } Pack RxCUI 2641918 Generic pack · GPCK

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Perampanel 1356552 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- FYCOMPA 1356558 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Perampanel Oral Tablet 1356556 SCDF
- Perampanel Oral Product 1356554 SCDG
- Perampanel Pill 1356555 SCDG
- Perampanel Oral Tablet [FYCOMPA] 1356560 SBDF
- FYCOMPA Oral Product 1356561 SBDG
- FYCOMPA Pill 1356562 SBDG
- Pack 746839 DF
- Oral Product 1151131 DFG
- +1 more in this family
Clinical & branded drugs 4

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Perampanel 2 MG Oral Tablet 1356557 SCD
- Perampanel 2 MG 1356553 SCDC
- Perampanel 2 MG Oral Tablet [FYCOMPA] 1356563 SBD
- Perampanel 2 MG [FYCOMPA] 1356559 SBDC
Packs 1

Fixed collections of drugs packaged and sold together, like dose packs.
- {14 (perampanel 2 MG Oral Tablet [FYCOMPA]) } Pack [Fycompa 2 MG 2-Week Sample Kit] 2641919 BPCK

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Perampanel 2 MG Oral Tablet SCD · 1356557
Perampanel 2 MG SCDC · 1356553
Perampanel Oral Tablet SCDF · 1356556
Perampanel Oral Product SCDG · 1356554
Perampanel Pill SCDG · 1356555

Brand-Name Concepts

Perampanel 2 MG Oral Tablet [FYCOMPA] SBD · 1356563
{14 (perampanel 2 MG Oral Tablet [FYCOMPA]) } Pack [Fycompa 2 MG 2-Week Sample Kit] BPCK · 2641919
Perampanel 2 MG [FYCOMPA] SBDC · 1356559
Perampanel Oral Tablet [FYCOMPA] SBDF · 1356560
FYCOMPA Oral Product SBDG · 1356561
FYCOMPA Pill SBDG · 1356562
FYCOMPA BN · 1356558

📦 FDA Products & Package NDCs

7 products · 15 package NDCs

15 package NDCs map to RxCUI 2641918 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
69616-0272-14	14 TABLET in 1 PACKAGE (69616-272-14)	Fycompa	Catalyst Pharmaceuticals, Inc.	2024-01-02
69616-0272-30	30 TABLET in 1 BOTTLE (69616-272-30)	Fycompa	Catalyst Pharmaceuticals, Inc.	2024-01-02
69616-0272-90	90 TABLET in 1 BOTTLE (69616-272-90)	Fycompa	Catalyst Pharmaceuticals, Inc.	2024-01-02
69616-0274-14	14 TABLET in 1 PACKAGE (69616-274-14)	Fycompa	Catalyst Pharmaceuticals, Inc.	2024-01-02
69616-0274-30	30 TABLET in 1 BOTTLE (69616-274-30)	Fycompa	Catalyst Pharmaceuticals, Inc.	2024-01-02
69616-0274-90	90 TABLET in 1 BOTTLE (69616-274-90)	Fycompa	Catalyst Pharmaceuticals, Inc.	2024-01-02
69616-0276-30	30 TABLET in 1 BOTTLE (69616-276-30)	Fycompa	Catalyst Pharmaceuticals, Inc.	2024-01-02
69616-0276-90	90 TABLET in 1 BOTTLE (69616-276-90)	Fycompa	Catalyst Pharmaceuticals, Inc.	2024-01-02
69616-0278-30	30 TABLET in 1 BOTTLE (69616-278-30)	Fycompa	Catalyst Pharmaceuticals, Inc.	2024-01-02
69616-0278-90	90 TABLET in 1 BOTTLE (69616-278-90)	Fycompa	Catalyst Pharmaceuticals, Inc.	2024-01-02
69616-0280-30	30 TABLET in 1 BOTTLE (69616-280-30)	Fycompa	Catalyst Pharmaceuticals, Inc.	2024-01-02
69616-0280-90	90 TABLET in 1 BOTTLE (69616-280-90)	Fycompa	Catalyst Pharmaceuticals, Inc.	2024-01-02
69616-0282-30	30 TABLET in 1 BOTTLE (69616-282-30)	Fycompa	Catalyst Pharmaceuticals, Inc.	2024-01-02
69616-0282-90	90 TABLET in 1 BOTTLE (69616-282-90)	Fycompa	Catalyst Pharmaceuticals, Inc.	2024-01-02
69616-0290-38	340 mL in 1 BOTTLE (69616-290-38)	Fycompa	Catalyst Pharmaceuticals, Inc.	2024-01-02

Observed labelers: Catalyst Pharmaceuticals, Inc. (15) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.